The FDA has released the second…
The FDA has released the second batch of recipients for [...]
More than a year and a half into…
More than a year and a half into Cullinan Therapeutics’ [...]
Axsome Therapeutics has wrapped…
Axsome Therapeutics has wrapped its hands around an epilepsy candidate [...]
UroGen is handing an anti-CTLA-4…
UroGen is handing an anti-CTLA-4 antibody back to Agenus after [...]
Amid the rapidly unfolding saga…
Amid the rapidly unfolding saga revolving around Metsera, a judge [...]
Some eight months into the launch…
Some eight months into the launch of Onapgo, the Parkinson’s [...]
In a letter to lawyers for Novo…
In a letter to lawyers for Novo and Metsera, an [...]
Teva Pharmaceuticals has a new…
Teva Pharmaceuticals has a new game plan for raising awareness [...]
The company remains confident in…
The company remains confident in the continued sales potential of [...]
Novo Nordisk is winding down a…
Novo Nordisk is winding down a range of early-stage programs [...]